Luke Johnson
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 detection and testing 1
-
- Homelessness and Social Issues 3
- Co-authors
- Nisreen A Alwan (2 shared papers)Kerry Gutridge (2 shared papers)Emma Plugge (2 shared papers)Julie Parkes (2 shared papers)Anjana Roy (1 shared paper)Kimberly A. Prather (1 shared paper)Martin McKee (1 shared paper)Trisha Greenhalgh (1 shared paper)
- Journals
- The Lancet (8 papers)The Lancet Public Health (2 papers)Systematic Reviews (1 paper)Med (1 paper)BMJ Open (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Luke Johnson
16 papers receiving 3.1k citations
Luke Johnson's Hit Papers
Peers
Comparison fields: 5 of 102
- Infectious Diseases 2.3k
- Applied Microbiology and Biotechnology 40
- Neurology 130
- Modeling and Simulation 43
- General Dentistry 3
Countries citing papers authored by Luke Johnson
This map shows the geographic impact of Luke Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Johnson more than expected).
Fields of papers citing papers by Luke Johnson
This network shows the impact of papers produced by Luke Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Johnson. The network helps show where Luke Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside Luke Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 1531 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 3 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 4 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 5 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 6 | 2021 | 86 | |
| 7 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 8 | 2021 | 71 | |
| 9 | 2021 | 52 | |
| 10 | 2022 | 31 | |
| 11 | 2018 | 17 | |
| 12 | 2017 | 6 | |
| 13 | 2023 | 5 | |
| 14 | 2019 | 3 | |
| 15 | 2020 | 3 | |
| 16 | 2020 | 2 | |
| 17 | 2025 | 0 |
About Luke Johnson
Luke Johnson is a scholar working on Infectious Diseases, General Health Professions, Clinical Psychology, Modeling and Simulation and Rheumatology, having authored 17 papers that have together received 3.2k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Homelessness and Social Issues (3 papers), COVID-19 and Mental Health (2 papers), Sex work and related issues (1 paper), SARS-CoV-2 detection and testing (1 paper), Urologic and reproductive health conditions (1 paper), Innovations in Medical Education (1 paper) and COVID-19 epidemiological studies (1 paper). The work is most often cited by research in Infectious Diseases (2.3k citations), Applied Microbiology and Biotechnology (40 citations), Neurology (130 citations), Modeling and Simulation (43 citations) and General Dentistry (3 citations). Luke Johnson has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Nisreen A Alwan, Kerry Gutridge, Emma Plugge, Julie Parkes, Anjana Roy, Kimberly A. Prather, Martin McKee, Trisha Greenhalgh, Paul J. Roderick and Hisham Ziauddeen. Their work appears in journals such as The Lancet, The Lancet Public Health, Systematic Reviews, Med and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.